Dialogue Volume 15 Issue 1 2019 - Page 64

DISCIPLINE SUMMARIES day and issued at least one prescription exceeding 20,000 OMEs. This prescribing exceeds the recom- mended watchful dose of 200 OMEs per day as set out in The Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain (v 5.6, April 30, 2010). In total, 19 patients were flagged by the NMS. The College retained a family medicine expert to review this matter. The expert concluded that Dr. Roy failed to meet the standard of practice of the profession in 13 of the 20 charts reviewed. The expert concluded that in 7 of the 20 charts reviewed, Dr. Roy exposed patients to a potential risk of harm due to the extremely high doses of opioids that were prescribed in combination with high doses of benzodiazepines and by not monitoring the pa- tients closely enough to ensure that they were taking the medications safely. DISGRACEFUL DISHONOURABLE OR UNPROFESSIONAL CONDUCT As a resolution, Dr. Roy entered into an undertak- ing with the College in June of 2017, requiring, among other things, that Dr. Roy practise under the guidance of a clinical supervisor acceptable to the College. If unable to obtain a clinical supervisor, Dr. Roy was required to cease to prescribe narcotic drugs, narcotic preparations, controlled drugs, benzodiaz- epines and other targeted substances, and all other monitored drugs. Dr. Roy obtained a clinical supervisor on July 19, 2017. However, on August 29, 2017, due to a poten- tial conflict of interest, Dr. Roy was notified that this clinical supervisor was no longer suitable. Dr. Roy was unable to find a suitable clinical super- visor by the extended deadline. In accordance with the terms of the undertaking, and the terms, condi- tions and limitations on his certificate of registration effective September 19, 2017, Dr. Roy was required to cease prescribing narcotic drugs, narcotic prepara- tions, controlled drugs, benzodiazepines and other targeted substances, and all other monitored drugs until such time as he has obtained a clinical supervi- sor acceptable to the College. This restriction ap- peared on the public register. NMS data demonstrated that Dr. Roy continued to prescribe monitored drugs between the period 64 DIALOGUE ISSUE 1, 2019 of September 19, 2017 and October 18, 2017. The Committee considered failure to comply with the undertaking made to the College to be a very serious act of professional misconduct. ORDER The Discipline Committee ordered: a three-month suspension of Dr. Roy’s certificate of registration; a reprimand; and successful completion of instruction in ethics. Dr. Roy was also ordered to pay to the Col- lege its hearing costs in the amount of $10,180. For complete details, please see the full decision at www.cpso.on.ca. Select Find a Doctor and enter the doctor’s name. At the conclusion of the hearing, Dr. Roy through his counsel waived his right to an appeal and the Commit- tee administered the public reprimand. DR. WILLIAM WARREN HETHRINGTON RUDD PRACTICE LOCATION: Toronto AREA OF PRACTICE: General Surgery HEARING INFORMATION: Plea of No Contest; State- ment of Uncontested Facts: Joint Submission on Penalty On August 10, 2018, the Discipline Committee found that Dr. Rudd committed an act of profes- sional misconduct, in that he has engaged in an act or omission relevant to the practice of medicine that, having regard to all the circumstances, would reason- ably be regarded by members as disgraceful, dishon- ourable or unprofessional. Patient A first saw Dr. Rudd in September 2013 for a complete anorectal examination which involved a sigmoidoscopy. She returned to see Dr. Rudd in September 2014 for an examination that included an anoscopy. When the examination was complete, Dr. Rudd did not take sufficient care to maintain Patient A’s privacy and spatial boundaries. This included touching one side of Patient A’s buttocks indicat- ing the end of the examination, removing the paper drape and helping Patient A pull up her trousers. Dr.